Alternative splicing isoforms in health and disease

  • Hyoung Kyu Kim
  • Michael Huy Cuong Pham
  • Kyung Soo Ko
  • Byoung Doo Rhee
  • Jin HanEmail author
Invited Review
Part of the following topical collections:
  1. Invited review


Alternative splicing (AS) of protein-coding messenger RNAs is an essential regulatory mechanism in eukaryotic gene expression that controls the proper function of proteins. It is also implicated in the physiological regulation of mitochondria and various ion channels. Considering that mis-splicing can result in various human diseases by modifying or abrogating important physiological protein functions, a fine-tuned balance of AS is essential for human health. Accumulated data highlight the importance of alternatively spliced isoforms in various diseases, including neurodegenerative disorders, cancer, immune and infectious diseases, cardiovascular diseases, and metabolic conditions. However, basic understanding of disease mechanisms and development of clinical applications still require the integration and interpretation of physiological roles of AS. This review discusses the roles of AS in health and various diseases, while highlighting potential AS-targeting therapeutic applications.


Cancer Neurodegenerative diseases Cardiovascular disease Metabolic disease Mitochondria Splicing factor Intron Exon skipping 



This study was supported by grants from the Priority Research Centers Program and Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2010-0020224, 2015R1A2A1A13001900, and 2015R1D1A1A01057937).


  1. 1.
    Alieva A, Shadrina MI, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Slominsky PA (2014) Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease. Biomed Res Int 2014:718732. PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Araki S, Dairiki R, Nakayama Y, Murai A, Miyashita R, Iwatani M, Nomura T, Nakanishi O (2015) Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing. PLoS One 10:e0116929. PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Arimura T, Inagaki N, Hayashi T, Shichi D, Sato A, Hinohara K, Vatta M, Towbin JA, Chikamori T, Yamashina A, Kimura A (2009) Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc Res 83:80–88. PubMedCrossRefGoogle Scholar
  4. 4.
    Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP (2008) Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster? Expert Opin Investig Drugs 17:969–972. PubMedCrossRefGoogle Scholar
  5. 5.
    Ayoubi TA, Van De Ven WJ (1996) Regulation of gene expression by alternative promoters. FASEB J 10:453–460PubMedCrossRefGoogle Scholar
  6. 6.
    Baralle FE, Giudice J (2017) Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol 18:437–451. PubMedCrossRefGoogle Scholar
  7. 7.
    Brauch KM, Karst ML, Herron KJ, de Andrade M, Pellikka PA, Rodeheffer RJ, Michels VV, Olson TM (2009) Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 54:930–941. PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Caceres JF, Kornblihtt AR (2002) Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 18:186–193PubMedCrossRefGoogle Scholar
  9. 9.
    Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5:495–502. PubMedCrossRefGoogle Scholar
  10. 10.
    Castanotto D, Stein CA (2014) Antisense oligonucleotides in cancer. Curr Opin Oncol 26:584–589. PubMedCrossRefGoogle Scholar
  11. 11.
    Chang JS, Fernand V, Zhang Y, Shin J, Jun HJ, Joshi Y, Gettys TW (2012) NT-PGC-1alpha protein is sufficient to link beta3-adrenergic receptor activation to transcriptional and physiological components of adaptive thermogenesis. J Biol Chem 287:9100–9111. PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Chang JS, Ha K (2017) An unexpected role for the transcriptional coactivator isoform NT-PGC-1alpha in the regulation of mitochondrial respiration in brown adipocytes. J Biol Chem 292:9958–9966. PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Chang YF, Imam JS, Wilkinson MF (2007) The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51–74. PubMedCrossRefGoogle Scholar
  14. 14.
    Chen L, Zhao M, Li J, Wang Y, Bao Q, Wu S, Deng X, Tang X, Wu W, Liu X (2017) Critical role of X-box binding protein 1 in NADPH oxidase 4-triggered cardiac hypertrophy is mediated by receptor interacting protein kinase 1. Cell Cycle 16:348–359. PubMedCrossRefGoogle Scholar
  15. 15.
    Chiocco MJ, Zhu X, Walther D, Pletnikova O, Troncoso JC, Uhl GR, Liu QR (2010) Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease. Subst Use Misuse 45:1809–1826. PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Chow LT, Gelinas RE, Broker TR, Roberts RJ (1977) An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12:1–8. PubMedCrossRefGoogle Scholar
  17. 17.
    Cieply B, Carstens RP (2015) Functional roles of alternative splicing factors in human disease. Wiley Interdiscip Rev RNA 6:311–326. PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Cooper TA (2005) Alternative splicing regulation impacts heart development. Cell 120:1–2. PubMedCrossRefGoogle Scholar
  19. 19.
    Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61:259–266. PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Correia JC, Ferreira DM, Ruas JL (2015) Intercellular: local and systemic actions of skeletal muscle PGC-1s. Trends Endocrinol Metab 26:305–314. PubMedCrossRefGoogle Scholar
  21. 21.
    Cunha SR, Le Scouarnec S, Schott JJ, Mohler PJ (2008) Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease. J Mol Cell Cardiol 45:724–734. PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Dahal LN, Basu N, Youssef H, Khanolkar RC, Barker RN, Erwig LP, Ward FJ (2016) Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther 18:180. PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Dally S, Bredoux R, Corvazier E, Andersen JP, Clausen JD, Dode L, Fanchaouy M, Gelebart P, Monceau V, Del Monte F, Gwathmey JK, Hajjar R, Chaabane C, Bobe R, Raies A, Enouf J (2006) Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c). Biochem J 395:249–258. PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Daniels L, Bell JR, Delbridge LM, McDonald FJ, Lamberts RR, Erickson JR (2015) The role of CaMKII in diabetic heart dysfunction. Heart Fail Rev 20:589–600. PubMedCrossRefGoogle Scholar
  25. 25.
    Dehghanian F, Hojati Z, Kay M (2014) New insights into VEGF-A alternative splicing: key regulatory switching in the pathological process. Avicenna J Med Biotechnol 6:192–199PubMedPubMedCentralGoogle Scholar
  26. 26.
    Dever SM, Rodriguez M, El-Hage N (2016) Beta-adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. J Neuro-Oncol 22:866–870. CrossRefGoogle Scholar
  27. 27.
    Ding JH, Xu X, Yang D, Chu PH, Dalton ND, Ye Z, Yeakley JM, Cheng H, Xiao RP, Ross J, Chen J, Fu XD (2004) Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J 23:885–896. PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Dlamini Z, Mokoena F, Hull R (2017) Abnormalities in alternative splicing in diabetes: therapeutic targets. J Mol Endocrinol 59:R93–R107. PubMedCrossRefGoogle Scholar
  29. 29.
    Dredge BK, Polydorides AD, Darnell RB (2001) The splice of life: alternative splicing and neurological disease. Nat Rev Neurosci 2:43–50. PubMedCrossRefGoogle Scholar
  30. 30.
    Dunning CJ, McKenzie M, Sugiana C, Lazarou M, Silke J, Connelly A, Fletcher JM, Kirby DM, Thorburn DR, Ryan MT (2007) Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 26:3227–3237. PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Elliott DA, Kim WS, Gorissen S, Halliday GM, Kwok JB (2012) Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease. Mov Disord 27:1004–1011. PubMedCrossRefGoogle Scholar
  32. 32.
    Escribano O, Beneit N, Rubio-Longas C, Lopez-Pastor AR, Gomez-Hernandez A (2017) The role of insulin receptor isoforms in diabetes and its metabolic and vascular complications. J Diabetes Res 2017:1403206. PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Eskens FA, Ramos FJ, Burger H, O'Brien JP, Piera A, de Jonge MJ, Mizui Y, Wiemer EA, Carreras MJ, Baselga J, Tabernero J (2013) Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin Cancer Res 19:6296–6304. PubMedCrossRefGoogle Scholar
  34. 34.
    Felkin LE, Narita T, Germack R, Shintani Y, Takahashi K, Sarathchandra P, Lopez-Olaneta MM, Gomez-Salinero JM, Suzuki K, Barton PJ, Rosenthal N, Lara-Pezzi E (2011) Calcineurin splicing variant calcineurin Abeta1 improves cardiac function after myocardial infarction without inducing hypertrophy. Circulation 123:2838–2847. PubMedCrossRefGoogle Scholar
  35. 35.
    Fernandez-Nogales M, Santos-Galindo M, Hernandez IH, Cabrera JR, Lucas JJ (2016) Faulty splicing and cytoskeleton abnormalities in Huntington's disease. Brain Pathol 26:772–778. PubMedCrossRefGoogle Scholar
  36. 36.
    Freyermuth F, Rau F, Kokunai Y, Linke T, Sellier C, Nakamori M, Kino Y, Arandel L, Jollet A, Thibault C, Philipps M, Vicaire S, Jost B, Udd B, Day JW, Duboc D, Wahbi K, Matsumura T, Fujimura H, Mochizuki H, Deryckere F, Kimura T, Nukina N, Ishiura S, Lacroix V, Campan-Fournier A, Navratil V, Chautard E, Auboeuf D, Horie M, Imoto K, Lee KY, Swanson MS, Lopez de Munain A, Inada S, Itoh H, Nakazawa K, Ashihara T, Wang E, Zimmer T, Furling D, Takahashi MP, Charlet-Berguerand N (2016) Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun 7:11067. PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Furihata C (2015) An active alternative splicing isoform of human mitochondrial 8-oxoguanine DNA glycosylase (OGG1). Genes Environ 37:21. PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Gao G, Dudley SC Jr (2013) SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia. Expert Rev Cardiovasc Ther 11:117–119. PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Gao G, Xie A, Huang SC, Zhou A, Zhang J, Herman AM, Ghassemzadeh S, Jeong EM, Kasturirangan S, Raicu M, Sobieski MA 2nd, Bhat G, Tatooles A, Benz EJ Jr, Kamp TJ, Dudley SC Jr (2011) Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure. Circulation 124:1124–1131. PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22:535–546. PubMedCrossRefGoogle Scholar
  41. 41.
    Gelebart P, Martin V, Enouf J, Papp B (2003) Identification of a new SERCA2 splice variant regulated during monocytic differentiation. Biochem Biophys Res Commun 303:676–684PubMedCrossRefGoogle Scholar
  42. 42.
    George CH, Rogers SA, Bertrand BM, Tunwell RE, Thomas NL, Steele DS, Cox EV, Pepper C, Hazeel CJ, Claycomb WC, Lai FA (2007) Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis. Circ Res 100:874–883. PubMedCrossRefGoogle Scholar
  43. 43.
    Giudice J, Xia Z, Wang ET, Scavuzzo MA, Ward AJ, Kalsotra A, Wang W, Wehrens XH, Burge CB, Li W, Cooper TA (2014) Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat Commun 5:3603. PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H, Riederer P, Moller HJ, Andreadis A, Henkel K, Stamm S (2006) The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem 96:635–644. PubMedCrossRefGoogle Scholar
  45. 45.
    Graveley BR (2001) Alternative splicing: increasing diversity in the proteomic world. Trends Genet 17:100–107PubMedCrossRefGoogle Scholar
  46. 46.
    Gray CB, Suetomi T, Xiang S, Mishra S, Blackwood EA, Glembotski CC, Miyamoto S, Westenbrink BD, Brown JH (2017) CaMKIIdelta subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-kappaB and TNF-alpha. J Mol Cell Cardiol 103:48–55. PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Gray P, Michelsen KS, Sirois CM, Lowe E, Shimada K, Crother TR, Chen S, Brikos C, Bulut Y, Latz E, Underhill D, Arditi M (2010) Identification of a novel human MD-2 splice variant that negatively regulates lipopolysaccharide-induced TLR4 signaling. J Immunol 184:6359–6366. PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Greene AL, Lalli MJ, Ji Y, Babu GJ, Grupp I, Sussman M, Periasamy M (2000) Overexpression of SERCA2b in the heart leads to an increase in sarcoplasmic reticulum calcium transport function and increased cardiac contractility. J Biol Chem 275:24722–24727. PubMedCrossRefGoogle Scholar
  49. 49.
    Gu Q, Jin N, Sheng H, Yin X, Zhu J (2011) Cyclic AMP-dependent protein kinase A regulates the alternative splicing of CaMKIIdelta. PLoS One 6:e25745. PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Guantes R, Rastrojo A, Neves R, Lima A, Aguado B, Iborra FJ (2015) Global variability in gene expression and alternative splicing is modulated by mitochondrial content. Genome Res 25:633–644. PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. PubMedCrossRefGoogle Scholar
  52. 52.
    Hartmann T, Bergsdorf C, Sandbrink R, Tienari PJ, Multhaup G, Ida N, Bieger S, Dyrks T, Weidemann A, Masters CL, Beyreuther K (1996) Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicing. J Biol Chem 271:13208–13214PubMedCrossRefGoogle Scholar
  53. 53.
    Hayakawa M, Sakashita E, Ueno E, Tominaga S, Hamamoto T, Kagawa Y, Endo H (2002) Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA. J Biol Chem 277:6974–6984. PubMedCrossRefGoogle Scholar
  54. 54.
    Heide J, Zhang F, Bigos KL, Mann SA, Carr VJ, Shannon Weickert C, Green MJ, Weinberger DR, Vandenberg JI (2016) Differential response to risperidone in schizophrenia patients by KCNH2 genotype and drug metabolizer status. Am J Psychiatry 173:53–59. PubMedCrossRefGoogle Scholar
  55. 55.
    Heinzen EL, Yoon W, Weale ME, Sen A, Wood NW, Burke JR, Welsh-Bohmer KA, Hulette CM, Sisodiya SM, Goldstein DB (2007) Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease. Genome Biol 8:R32. PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Hinrich AJ, Jodelka FM, Chang JL, Brutman D, Bruno AM, Briggs CA, James BD, Stutzmann GE, Bennett DA, Miller SA, Rigo F, Marr RA, Hastings ML (2016) Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. EMBO Mol Med 8:328–345. PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Hong DS, Kurzrock R, Naing A, Wheler JJ, Falchook GS, Schiffman JS, Faulkner N, Pilat MJ, O'Brien J, LoRusso P (2014) A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors. Investig New Drugs 32:436–444. CrossRefGoogle Scholar
  58. 58.
    Hsu TY, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, Echeverria GV, Sun T, Kurley SJ, Tyagi S, Karlin KL, Dominguez-Vidana R, Hartman JD, Renwick A, Scorsone K, Bernardi RJ, Skinner SO, Jain A, Orellana M, Lagisetti C, Golding I, Jung SY, Neilson JR, Zhang XH, Cooper TA, Webb TR, Neel BG, Shaw CA, Westbrook TF (2015) The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature 525:384–388. PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Hughes T, Hansson L, Sonderby IE, Athanasiu L, Zuber V, Tesli M, Song J, Hultman CM, Bergen SE, Landen M, Melle I, Andreassen OA, Djurovic S (2016) A loss-of-function variant in a minor isoform of ANK3 protects against bipolar disorder and schizophrenia. Biol Psychiatry 80:323–330. PubMedCrossRefGoogle Scholar
  60. 60.
    Hurtado C, Prociuk M, Maddaford TG, Dibrov E, Mesaeli N, Hryshko LV, Pierce GN (2006) Cells expressing unique Na+/Ca2+ exchange (NCX1) splice variants exhibit different susceptibilities to Ca2+ overload. Am J Physiol Heart Circ Physiol 290:H2155–H2162. PubMedCrossRefGoogle Scholar
  61. 61.
    Ingelsson M, Ramasamy K, Cantuti-Castelvetri I, Skoglund L, Matsui T, Orne J, Kowa H, Raju S, Vanderburg CR, Augustinack JC, de Silva R, Lees AJ, Lannfelt L, Growdon JH, Frosch MP, Standaert DG, Irizarry MC, Hyman BT (2006) No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol 112:439–449. PubMedCrossRefGoogle Scholar
  62. 62.
    Ishunina TA, Swaab DF (2012) Decreased alternative splicing of estrogen receptor-alpha mRNA in the Alzheimer's disease brain. Neurobiol Aging 33:286–296.e283. PubMedCrossRefGoogle Scholar
  63. 63.
    Jensen DP, Urhammer SA, Eiberg H, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O (2006) Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites. Mol Genet Metab 89:360–367. PubMedCrossRefGoogle Scholar
  64. 64.
    Juan-Mateu J, Rech TH, Villate O, Lizarraga-Mollinedo E, Wendt A, Turatsinze JV, Brondani LA, Nardelli TR, Nogueira TC, Esguerra JL, Alvelos MI, Marchetti P, Eliasson L, Eizirik DL (2017) Neuron-enriched RNA-binding proteins regulate pancreatic beta cell function and survival. J Biol Chem 292:3466–3480. PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Jun HJ, Gettys TW, Chang JS (2012) Transcriptional activity of PGC-1alpha and NT-PGC-1alpha is differentially regulated by Twist-1 in brown fat metabolism. PPAR Res 2012:320454. PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H, Tani T, Horinouchi S, Yoshida M (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 3:576–583. PubMedCrossRefGoogle Scholar
  67. 67.
    Kalivendi SV, Yedlapudi D, Hillard CJ, Kalyanaraman B (2010) Oxidants induce alternative splicing of alpha-synuclein: implications for Parkinson's disease. Free Radic Biol Med 48:377–383. PubMedCrossRefGoogle Scholar
  68. 68.
    Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, Burge CB, Cooper TA (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A 105:20333–20338. PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Karambataki M, Malousi A, Tzimagiorgis G, Haitoglou C, Fragou A, Georgiou E, Papadopoulou F, Krassas GE, Kouidou S (2017) Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes. Biomed Rep 6:146–158. PubMedCrossRefGoogle Scholar
  70. 70.
    Keren H, Lev-Maor G, Ast G (2010) Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 11:345–355. PubMedCrossRefGoogle Scholar
  71. 71.
    Kim E, Goren A, Ast G (2008) Alternative splicing and disease. RNA Biol 5:17–19PubMedCrossRefGoogle Scholar
  72. 72.
    Kim HK, Nilius B, Kim N, Ko KS, Rhee BD, Han J (2016) Cardiac response to oxidative stress induced by mitochondrial dysfunction. Rev Physiol Biochem Pharmacol 170:101–127. PubMedCrossRefGoogle Scholar
  73. 73.
    Kobylecki C, Crossman AR, Ravenscroft P (2013) Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia. Exp Neurol 247:476–484. PubMedCrossRefGoogle Scholar
  74. 74.
    Kong SW, Hu YW, Ho JW, Ikeda S, Polster S, John R, Hall JL, Bisping E, Pieske B, dos Remedios CG, Pu WT (2010) Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet 3:138–146. PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol 3:570–575. PubMedCrossRefGoogle Scholar
  76. 76.
    Lai MK, Esiri MM, Tan MG (2014) Genome-wide profiling of alternative splicing in Alzheimer's disease. Genom Data 2:290–292. PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Lara-Pezzi E, Gomez-Salinero J, Gatto A, Garcia-Pavia P (2013) The alternative heart: impact of alternative splicing in heart disease. J Cardiovasc Transl Res 6:945–955. PubMedCrossRefGoogle Scholar
  78. 78.
    Lee C, Low CY, Francis PT, Attems J, Wong PT, Lai MK, Tan MG (2016) An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease. J Neurochem 136:637–650. PubMedCrossRefGoogle Scholar
  79. 79.
    Lee C, Low CY, Wong SY, Lai MK, Tan MG (2017) Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes. Sci Rep 7:43651. PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Lee SC, Abdel-Wahab O (2016) Therapeutic targeting of splicing in cancer. Nat Med 22:976–986. PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Li G, Wang J, Liao P, Bartels P, Zhang H, Yu D, Liang MC, Poh KK, Yu CY, Jiang F, Yong TF, Wong YP, Hu Z, Huang H, Zhang G, Galupo MJ, Bian JS, Ponniah S, Trasti SL, See K, Foo R, Hoppe UC, Herzig S, Soong TW (2017) Exclusion of alternative exon 33 of CaV1.2 calcium channels in heart is proarrhythmogenic. Proc Natl Acad Sci U S A 114:E4288–E4295. PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Liao P, Soong TW (2010) Understanding alternative splicing of Cav1.2 calcium channels for a new approach towards individualized medicine. J Biomed Res 24:181–186. PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Liao P, Yong TF, Liang MC, Yue DT, Soong TW (2005) Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. Cardiovasc Res 68:197–203. PubMedCrossRefGoogle Scholar
  84. 84.
    Lin Y, Tan KT, Liu J, Kong X, Huang Z, Xu XQ (2017) Global profiling of Rbm24 bound RNAs uncovers a multi-tasking RNA binding protein. Int J Biochem Cell Biol 94:10–21. PubMedCrossRefGoogle Scholar
  85. 85.
    Lin Z, Xu W, Li C, Wang Y, Yang L, Zou B, Gao S, Yao W, Song Z, Liu G (2017) Beta-8-oxoguanine DNA glycosylase overexpression reduces oxidative stress-induced mitochondrial dysfunction and apoptosis through the JNK signaling pathway in human bronchial epithelial cells. DNA Cell Biol 36:1071–1080. PubMedCrossRefGoogle Scholar
  86. 86.
    Liu S, Zhao K, Su X, Lu L, Zhao H, Zhang X, Wang Y, Wu C, Chen J, Zhou Y, Hu X, Wang Y, Lu M, Chen X, Pei R (2017) MITA/STING and its alternative splicing isoform MRP restrict hepatitis B virus replication. PLoS One 12:e0169701. PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Lopez-Olaneta MM, Villalba M, Gomez-Salinero JM, Jimenez-Borreguero LJ, Breckenridge R, Ortiz-Sanchez P, Garcia-Pavia P, Ibanez B, Lara-Pezzi E (2014) Induction of the calcineurin variant CnAbeta1 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularization. Cardiovasc Res 102:396–406. PubMedCrossRefGoogle Scholar
  88. 88.
    Love JE, Hayden EJ, Rohn TT (2015) Alternative splicing in Alzheimer's disease. J Parkinsons Dis Alzheimers Dis 2.
  89. 89.
    Luzina IG, Lockatell V, Lavania S, Pickering EM, Kang PH, Bashkatova YN, Andreev SM, Atamas SP (2012) Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma. Cytokine 58:20–26. PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Ma J, Lu L, Guo W, Ren J, Yang J (2016) Emerging role for RBM20 and its splicing substrates in cardiac function and heart failure. Curr Pharm Des 22:4744–4751PubMedCrossRefGoogle Scholar
  91. 91.
    Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke WA (2004) Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 95:708–716. PubMedCrossRefGoogle Scholar
  92. 92.
    Malakar P, Chartarifsky L, Hija A, Leibowitz G, Glaser B, Dor Y, Karni R (2016) Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival. Sci Rep 6:31222. PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Maracchioni A, Totaro A, Angelini DF, Di Penta A, Bernardi G, Carri MT, Achsel T (2007) Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration. J Neurochem 100:142–153. PubMedCrossRefGoogle Scholar
  94. 94.
    Mardon HJ, Sebastio G, Baralle FE (1987) A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res 15:7725–7733PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Martin D, Li Y, Yang J, Wang G, Margariti A, Jiang Z, Yu H, Zampetaki A, Hu Y, Xu Q, Zeng L (2014) Unspliced X-box-binding protein 1 (XBP1) protects endothelial cells from oxidative stress through interaction with histone deacetylase 3. J Biol Chem 289:30625–30634. PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Martinez-Redondo V, Jannig PR, Correia JC, Ferreira DM, Cervenka I, Lindvall JM, Sinha I, Izadi M, Pettersson-Klein AT, Agudelo LZ, Gimenez-Cassina A, Brum PC, Dahlman-Wright K, Ruas JL (2016) Peroxisome proliferator-activated receptor gamma coactivator-1 alpha isoforms selectively regulate multiple splicing events on target genes. J Biol Chem 291:15169–15184. PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Martinez-Redondo V, Pettersson AT, Ruas JL (2015) The hitchhiker's guide to PGC-1alpha isoform structure and biological functions. Diabetologia 58:1969–1977. PubMedCrossRefGoogle Scholar
  98. 98.
    Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R, Tabaton M, Robello M, Gatta E, Russo C, Florio T, Dieci G, Cancedda R, Pagano A (2011) 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 41:308–317. PubMedCrossRefGoogle Scholar
  99. 99.
    McFadden JP, Baker BS, Powles AV, Fry L (2010) Psoriasis and extra domain A fibronectin loops. Br J Dermatol 163:5–11. PubMedCrossRefGoogle Scholar
  100. 100.
    Michel LY, Verkaart S, Koopman WJ, Willems PH, Hoenderop JG, Bindels RJ (2014) Function and regulation of the Na+-Ca2+ exchanger NCX3 splice variants in brain and skeletal muscle. J Biol Chem 289:11293–11303. PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Mills JD, Sheahan PJ, Lai D, Kril JJ, Janitz M, Sutherland GT (2014) The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients. Mol Biol Rep 41:6365–6376. PubMedCrossRefGoogle Scholar
  102. 102.
    Miura S, Kai Y, Kamei Y, Ezaki O (2008) Isoform-specific increases in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to beta2-adrenergic receptor activation and exercise. Endocrinology 149:4527–4533. PubMedCrossRefGoogle Scholar
  103. 103.
    Moore MJ, Wang Q, Kennedy CJ, Silver PA (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell 142:625–636. PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Morikawa T, Manabe T, Ito Y, Yamada S, Yoshimi A, Nagai T, Ozaki N, Mayeda A (2010) The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients. Neurochem Int 56:736–739. PubMedCrossRefGoogle Scholar
  105. 105.
    Mourich DV, Oda SK, Schnell FJ, Crumley SL, Hauck LL, Moentenich CA, Marshall NB, Hinrichs DJ, Iversen PL (2014) Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice. Nucleic Acid Ther 24:114–126. PubMedCrossRefGoogle Scholar
  106. 106.
    Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Asp Med 34:121–138. CrossRefGoogle Scholar
  107. 107.
    Murray A, Donger C, Fenske C, Spillman I, Richard P, Dong YB, Neyroud N, Chevalier P, Denjoy I, Carter N, Syrris P, Afzal AR, Patton MA, Guicheney P, Jeffery S (1999) Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation 100:1077–1084PubMedCrossRefGoogle Scholar
  108. 108.
    Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N (2001) Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195–200. PubMedCrossRefGoogle Scholar
  109. 109.
    Nutter CA, Jaworski EA, Verma SK, Deshmukh V, Wang Q, Botvinnik OB, Lozano MJ, Abass IJ, Ijaz T, Brasier AR, Garg NJ, Wehrens XHT, Yeo GW, Kuyumcu-Martinez MN (2016) Dysregulation of RBFOX2 is an early event in cardiac pathogenesis of diabetes. Cell Rep 15:2200–2213. PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Ohno K, Rahman MA, Nazim M, Nasrin F, Lin Y, Takeda JI, Masuda A (2017) Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction. J Neurochem.
  111. 111.
    Orengo JP, Cooper TA (2007) Alternative splicing in disease. Adv Exp Med Biol 623:212–223PubMedCrossRefGoogle Scholar
  112. 112.
    Organization WH (2016) Global report on diabetes. World Health OrganizationGoogle Scholar
  113. 113.
    Panelli D, Lorusso F, Papa F, Sardanell A, Papa S (2013) Alternative splicing and nonsense mediated decay in mitochondrial complex-I biogenesis and its implication in human diseases. J Bioanal Biomed s3.
  114. 114.
    Paronetto MP, Passacantilli I, Sette C (2016) Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ 23:1919–1929. PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Phillips MI, Costales J, Lee RJ, Oliveira E, Burns AB (2015) Antisense therapy for cardiovascular diseases. Curr Pharm Des 21:4417–4426PubMedCrossRefGoogle Scholar
  116. 116.
    Poltorak Z, Cohen T, Neufeld G (2000) The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz 25:126–129PubMedCrossRefGoogle Scholar
  117. 117.
    Poon KL, Tan KT, Wei YY, Ng CP, Colman A, Korzh V, Xu XQ (2012) RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovasc Res 94:418–427. PubMedCrossRefGoogle Scholar
  118. 118.
    Popov DV, Bachinin AV, Lysenko EA, Miller TF, Vinogradova OL (2014) Exercise-induced expression of peroxisome proliferator-activated receptor gamma coactivator-1alpha isoforms in skeletal muscle of endurance-trained males. J Physiol Sci 64:317–323. PubMedCrossRefGoogle Scholar
  119. 119.
    Rajan S, Jagatheesan G, Karam CN, Alves ML, Bodi I, Schwartz A, Bulcao CF, D'Souza KM, Akhter SA, Boivin GP, Dube DK, Petrashevskaya N, Herr AB, Hullin R, Liggett SB, Wolska BM, Solaro RJ, Wieczorek DF (2010) Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform. Circulation 121:410–418. PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L (1995) Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 270:28257–28267PubMedCrossRefGoogle Scholar
  121. 121.
    Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA, Ikeda M, Holman K, Lin C, Lukiw WJ, de Jong PJ, Fraser PE, Rommens JM, St George-Hyslop P (1997) Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 40:415–424. PubMedCrossRefGoogle Scholar
  122. 122.
    Roybal GA, Jurica MS (2010) Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation. Nucleic Acids Res 38:6664–6672. PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM (2012) A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151:1319–1331. PubMedPubMedCentralCrossRefGoogle Scholar
  124. 124.
    Ryan M, Wong WC, Brown R, Akbani R, Su X, Broom B, Melott J, Weinstein J (2016) TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res 44:D1018–D1022. PubMedCrossRefGoogle Scholar
  125. 125.
    Salton M, Kasprzak WK, Voss T, Shapiro BA, Poulikakos PI, Misteli T (2015) Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing. Nat Commun 6:7103. PubMedPubMedCentralCrossRefGoogle Scholar
  126. 126.
    Sammeth M, Foissac S, Guigo R (2008) A general definition and nomenclature for alternative splicing events. PLoS Comput Biol 4:e1000147. PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Sanchez-Caballero L, Ruzzenente B, Bianchi L, Assouline Z, Barcia G, Metodiev MD, Rio M, Funalot B, van den Brand MA, Guerrero-Castillo S, Molenaar JP, Koolen D, Brandt U, Rodenburg RJ, Nijtmans LG, Rotig A (2016) Mutations in Complex I assembly factor TMEM126B result in muscle weakness and isolated Complex I deficiency. Am J Hum Genet 99:208–216. PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Santini MP, Lexow J, Borsellino G, Slonimski E, Zarrinpashneh E, Poggioli T, Rosenthal N (2011) IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochem Biophys Res Commun 410:201–207. PubMedCrossRefGoogle Scholar
  129. 129.
    Satoh N, Yokoyama C, Itamura N, Miyajima-Nakano Y, Hisatomi H (2015) Alternative splicing isoform in succinate dehydrogenase complex, subunit C causes downregulation of succinate-coenzyme Q oxidoreductase activity in mitochondria. Oncol Lett 9:330–334. PubMedCrossRefGoogle Scholar
  130. 130.
    Sawada T, Minamino T, Fu HY, Asai M, Okuda K, Isomura T, Yamazaki S, Asano Y, Okada K, Tsukamoto O, Sanada S, Asanuma H, Asakura M, Takashima S, Kitakaze M, Komuro I (2010) X-box binding protein 1 regulates brain natriuretic peptide through a novel AP1/CRE-like element in cardiomyocytes. J Mol Cell Cardiol 48:1280–1289. PubMedCrossRefGoogle Scholar
  131. 131.
    Scacco S, Petruzzella V, Budde S, Vergari R, Tamborra R, Panelli D, van den Heuvel LP, Smeitink JA, Papa S (2003) Pathological mutations of the human NDUFS4 gene of the 18-kDa (AQDQ) subunit of complex I affect the expression of the protein and the assembly and function of the complex. J Biol Chem 278:44161–44167. PubMedCrossRefGoogle Scholar
  132. 132.
    Schoenauer R, Emmert MY, Felley A, Ehler E, Brokopp C, Weber B, Nemir M, Faggian GG, Pedrazzini T, Falk V, Hoerstrup SP, Agarkova I (2011) EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol 106:233–247. PubMedCrossRefGoogle Scholar
  133. 133.
    Schommartz T, Loroch S, Alawi M, Grundhoff A, Sickmann A, Brune W (2016) Functional dissection of an alternatively spliced herpesvirus gene by splice site mutagenesis. J Virol 90:4626–4636. PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Serena G, Yan S, Camhi S, Patel S, Lima RS, Sapone A, Leonard MM, Mukherjee R, Nath BJ, Lammers KM, Fasano A (2017) Proinflammatory cytokine interferon-gamma and microbiome-derived metabolites dictate epigenetic switch between forkhead box protein 3 isoforms in coeliac disease. Clin Exp Immunol 187:490–506. PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Shehadeh LA, Yu K, Wang L, Guevara A, Singer C, Vance J, Papapetropoulos S (2010) SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 5:e9104. PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Shi J, Qian W, Yin X, Iqbal K, Grundke-Iqbal I, Gu X, Ding F, Gong CX, Liu F (2011) Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J Biol Chem 286:14639–14648. PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Silvennoinen M, Ahtiainen JP, Hulmi JJ, Pekkala S, Taipale RS, Nindl BC, Laine T, Hakkinen K, Selanne H, Kyrolainen H, Kainulainen H (2015) PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise. Physiol Rep 3.
  138. 138.
    Smith CW, Valcarcel J (2000) Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 25:381–388PubMedCrossRefGoogle Scholar
  139. 139.
    Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431–432. PubMedCrossRefGoogle Scholar
  140. 140.
    Soreq L, Bergman H, Israel Z, Soreq H (2012) Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes. Neurodegener Dis 10:203–206. PubMedCrossRefGoogle Scholar
  141. 141.
    Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT (2005) Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A 102:8089–8096; discussion 8086-8088. PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, Keating MT (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19–31. PubMedCrossRefGoogle Scholar
  143. 143.
    Sterne-Weiler T, Sanford JR (2014) Exon identity crisis: disease-causing mutations that disrupt the splicing code. Genome Biol 15:201. PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Sveen A, Kilpinen S, Ruusulehto A, Lothe RA, Skotheim RI (2016) Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35:2413–2427. PubMedCrossRefGoogle Scholar
  145. 145.
    Tadaishi M, Miura S, Kai Y, Kano Y, Oishi Y, Ezaki O (2011) Skeletal muscle-specific expression of PGC-1alpha-b, an exercise-responsive isoform, increases exercise capacity and peak oxygen uptake. PLoS One 6:e28290. PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Biochim Biophys Acta 1792:14–26. PubMedCrossRefGoogle Scholar
  147. 147.
    Tian B, Manley JL (2017) Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol 18:18–30. PubMedCrossRefGoogle Scholar
  148. 148.
    Tomita N, Morishita R (2004) Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. Curr Pharm Des 10:797–803PubMedCrossRefGoogle Scholar
  149. 149.
    Troncoso R, Ibarra C, Vicencio JM, Jaimovich E, Lavandero S (2014) New insights into IGF-1 signaling in the heart. Trends Endocrinol Metab 25:128–137. PubMedCrossRefGoogle Scholar
  150. 150.
    Tumurkhuu G, Dagvadorj J, Jones HD, Chen S, Shimada K, Crother TR, Arditi M (2015) Alternatively spliced myeloid differentiation protein-2 inhibits TLR4-mediated lung inflammation. J Immunol 194:1686–1694. PubMedPubMedCentralCrossRefGoogle Scholar
  151. 151.
    van den Bosch L (1998) Regulation of alternative processing of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA2) gene transcripts during muscle differentiation. Verh K Acad Geneeskd Belg 60:441–461PubMedGoogle Scholar
  152. 152.
    Ver Heyen M, Heymans S, Antoons G, Reed T, Periasamy M, Awede B, Lebacq J, Vangheluwe P, Dewerchin M, Collen D, Sipido K, Carmeliet P, Wuytack F (2001) Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ Res 89:838–846CrossRefGoogle Scholar
  153. 153.
    Villate O, Turatsinze JV, Mascali LG, Grieco FA, Nogueira TC, Cunha DA, Nardelli TR, Sammeth M, Salunkhe VA, Esguerra JL, Eliasson L, Marselli L, Marchetti P, Eizirik DL (2014) Nova1 is a master regulator of alternative splicing in pancreatic beta cells. Nucleic Acids Res 42:11818–11830. PubMedPubMedCentralCrossRefGoogle Scholar
  154. 154.
    Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, Giuliani A, Rosenthal N (2012) mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11:139–149. PubMedCrossRefGoogle Scholar
  155. 155.
    Wahbi K, Algalarrondo V, Becane HM, Fressart V, Beldjord C, Azibi K, Lazarus A, Berber N, Radvanyi-Hoffman H, Stojkovic T, Behin A, Laforet P, Eymard B, Hatem S, Duboc D (2013) Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1. Arch Cardiovasc Dis 106:635–643. PubMedCrossRefGoogle Scholar
  156. 156.
    Wang Z, Burge CB (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14:802–813. PubMedPubMedCentralCrossRefGoogle Scholar
  157. 157.
    Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE (1995) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11:434–437. PubMedCrossRefGoogle Scholar
  158. 158.
    Weeland CJ, van den Hoogenhof MM, Beqqali A, Creemers EE (2015) Insights into alternative splicing of sarcomeric genes in the heart. J Mol Cell Cardiol 81:107–113. PubMedCrossRefGoogle Scholar
  159. 159.
    Wei C, Qiu J, Zhou Y, Xue Y, Hu J, Ouyang K, Banerjee I, Zhang C, Chen B, Li H, Chen J, Song LS, Fu XD (2015) Repression of the central splicing regulator RBFox2 is functionally linked to pressure overload-induced heart failure. Cell Rep.
  160. 160.
    Westenbrink BD, Ling H, Divakaruni AS, Gray CB, Zambon AC, Dalton ND, Peterson KL, Gu Y, Matkovich SJ, Murphy AN, Miyamoto S, Dorn GW 2nd, Heller Brown J (2015) Mitochondrial reprogramming induced by CaMKIIdelta mediates hypertrophy decompensation. Circ Res 116:e28–e39. PubMedPubMedCentralCrossRefGoogle Scholar
  161. 161.
    Xu X, Yang D, Ding JH, Wang W, Chu PH, Dalton ND, Wang HY, Bermingham JR Jr, Ye Z, Liu F, Rosenfeld MG, Manley JL, Ross J Jr, Chen J, Xiao RP, Cheng H, Fu XD (2005) ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120:59–72. PubMedCrossRefGoogle Scholar
  162. 162.
    Yamankurt G, Wu HC, McCarthy M, Cunha SR (2015) Exon organization and novel alternative splicing of Ank3 in mouse heart. PLoS One 10:e0128177. PubMedPubMedCentralCrossRefGoogle Scholar
  163. 163.
    Yoshioka T, Inagaki K, Noguchi T, Sakai M, Ogawa W, Hosooka T, Iguchi H, Watanabe E, Matsuki Y, Hiramatsu R, Kasuga M (2009) Identification and characterization of an alternative promoter of the human PGC-1alpha gene. Biochem Biophys Res Commun 381:537–543. PubMedCrossRefGoogle Scholar
  164. 164.
    Zeng L, Xiao Q, Chen M, Margariti A, Martin D, Ivetic A, Xu H, Mason J, Wang W, Cockerill G, Mori K, Li JY, Chien S, Hu Y, Xu Q (2013) Vascular endothelial cell growth-activated XBP1 splicing in endothelial cells is crucial for angiogenesis. Circulation 127:1712–1722. PubMedCrossRefGoogle Scholar
  165. 165.
    Zhang J, Manley JL (2013) Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov 3:1228–1237. PubMedCrossRefGoogle Scholar
  166. 166.
    Zhang L, Vincent GM, Baralle M, Baralle FE, Anson BD, Benson DW, Whiting B, Timothy KW, Carlquist J, January CT, Keating MT, Splawski I (2004) An intronic mutation causes long QT syndrome. J Am Coll Cardiol 44:1283–1291. PubMedCrossRefGoogle Scholar
  167. 167.
    Zhang T, Lin Y, Liu J, Zhang ZG, Fu W, Guo LY, Pan L, Kong X, Zhang MK, Lu YH, Huang ZR, Xie Q, Li WH, Xu XQ (2016) Rbm24 regulates alternative splicing switch in embryonic stem cell cardiac lineage differentiation. Stem Cells 34:1776–1789. PubMedCrossRefGoogle Scholar
  168. 168.
    Zhang X, Zhou T, Yang J, Lin Y, Shi J, Zhang X, Frabutt DA, Zeng X, Li S, Venta PJ, Zheng YH (2017) Identification of SERINC5-001 as the predominant spliced isoform for HIV-1 restriction. J Virol 91.
  169. 169.
    Zhang Y, Huypens P, Adamson AW, Chang JS, Henagan TM, Boudreau A, Lenard NR, Burk D, Klein J, Perwitz N, Shin J, Fasshauer M, Kralli A, Gettys TW (2009) Alternative mRNA splicing produces a novel biologically active short isoform of PGC-1alpha. J Biol Chem 284:32813–32826. PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Zhao P, Turdi S, Dong F, Xiao X, Su G, Zhu X, Scott GI, Ren J (2009) Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 32:100–107. PubMedPubMedCentralCrossRefGoogle Scholar
  171. 171.
    Zhou H, Liu X, Yu R, Long T, Zhao R, Liu H, Xu Y, Liang JG, Liang P (2016) Alternative splicing directs two IL-20R2 isoforms and is responsible for the incomplete gene knockout via the exon I ablation. Genes Immun 17:220–227. PubMedCrossRefGoogle Scholar
  172. 172.
    Zhu H, Ding Q (2015) Lower expression level of two RAGE alternative splicing isoforms in Alzheimer's disease. Neurosci Lett 597:66–70. PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Hyoung Kyu Kim
    • 1
    • 2
  • Michael Huy Cuong Pham
    • 3
  • Kyung Soo Ko
    • 1
  • Byoung Doo Rhee
    • 1
  • Jin Han
    • 1
    Email author
  1. 1.National Research Laboratory for Mitochondrial Signaling, Department of Physiology, Department of Health Sciences and Technology, BK21 Plus Project Team, Cardiovascular and Metabolic Disease CenterInje University College of MedicineBusanSouth Korea
  2. 2.Department of Integrated Biomedical ScienceInje University College of MedicineBusanSouth Korea
  3. 3.School of medicineUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations